Woolard Matthew D, Wilson Justin E, Hensley Lucinda L, Jania Leigh A, Kawula Thomas H, Drake James R, Frelinger Jeffrey A
Department of Microbiology and Immunology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA.
J Immunol. 2007 Feb 15;178(4):2065-74. doi: 10.4049/jimmunol.178.4.2065.
Francisella tularensis is a highly infectious bacterial pathogen, and is likely to have evolved strategies to evade and subvert the host immune response. In this study, we show that F. tularensis infection of macrophages alters T cell responses in vitro, by blocking T cell proliferation and promoting a Th2-like response. We demonstrate that a soluble mediator is responsible for this effect and identify it as PGE(2). Supernatants from F. tularensis-infected macrophages inhibited IL-2 secretion from both MHC class I and MHC class II-restricted T cell hybridomas, as well as enhanced a Th2-like response by inducing increased production of IL-5. Furthermore, the soluble mediator blocked proliferation of naive MHC class I-restricted T cells when stimulated with cognate tetramer. Indomethacin treatment partially restored T cell proliferation and lowered IL-5 production to wild-type levels. Macrophages produced PGE(2) when infected with F. tularensis, and treatment of infected macrophages with indomethacin, a cyclooxygenase-1/cyclooxygenase-2 inhibitor, blocked PGE(2) production. To further demonstrate that PGE(2) was responsible for skewing of T cell responses, we infected macrophages from membrane PGE synthase 1 knockout mice (mPGES1(-/-)) that cannot produce PGE(2). Supernatants from F. tularensis-infected membrane PGE synthase 1(-/-) macrophages did not inhibit T cell proliferation. Furthermore, treatment of T cells with PGE(2) recreated the effects seen with infected supernatant. From these data, we conclude that F. tularensis can alter host T cell responses by causing macrophages to produce PGE(2). This study defines a previously unknown mechanism used by F. tularensis to modulate adaptive immunity.
土拉弗朗西斯菌是一种极具传染性的细菌病原体,很可能已经进化出逃避和颠覆宿主免疫反应的策略。在本研究中,我们发现土拉弗朗西斯菌感染巨噬细胞会在体外改变T细胞反应,其方式是阻断T细胞增殖并促进类似Th2的反应。我们证明一种可溶性介质对此效应负责,并将其鉴定为前列腺素E2(PGE2)。土拉弗朗西斯菌感染的巨噬细胞的上清液抑制了MHC I类和MHC II类限制性T细胞杂交瘤分泌白细胞介素-2(IL-2),并且通过诱导IL-5产生增加增强了类似Th2的反应。此外,当用同源四聚体刺激时,这种可溶性介质阻断了天然MHC I类限制性T细胞的增殖。吲哚美辛处理部分恢复了T细胞增殖,并将IL-5产生降低至野生型水平。巨噬细胞在感染土拉弗朗西斯菌时会产生PGE2,用环氧化酶-1/环氧化酶-2抑制剂吲哚美辛处理感染的巨噬细胞可阻断PGE2的产生。为了进一步证明PGE2是T细胞反应偏向的原因,我们用不能产生PGE2的膜型前列腺素E合酶1基因敲除小鼠(mPGES1(-/-))的巨噬细胞进行感染。土拉弗朗西斯菌感染的膜型前列腺素E合酶1(-/-)巨噬细胞的上清液没有抑制T细胞增殖。此外,用PGE2处理T细胞重现了感染上清液所产生的效应。根据这些数据,我们得出结论,土拉弗朗西斯菌可通过使巨噬细胞产生PGE2来改变宿主T细胞反应。本研究确定了土拉弗朗西斯菌用于调节适应性免疫的一种前所未知的机制。